Clinical Trial

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Study acronym: CLARITY
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-05-22; most recent amendment 2026-01-08.
Status change: Recruiting → Active, Not Recruiting 2026-01-08
Status change: Not Yet Recruiting → Recruiting 2024-10-21
Trial Details
NCT Number NCT06431373
Lead Sponsor Priovant Therapeutics, Inc.
Conditions Uveitis, Posterior, Uveitis, Intermediate, Uveitis
Enrollment 371 participants
Start Date 2024-09-11
Primary Completion 2026-09-11 (estimated)
Study Completion 2028-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-12